A buildup of Russian troops along the Ukrainian border sent the markets tumbling to a sharply lower close with the Dow plunging 139 points to 16,429. Nasdaq dropped 31 points to 4352.
On the upside
TriNet Group (NYSE: TNET) reported higher second quarter earnings and revenue that beat analyst expectations.
Qualys (Nasdaq: QLYS) reported sharply higher second quarter earnings that nearly doubled prompting the company to lift its full year earnings and revenue outlook.
The European Commission granted orphan drug status to Raptor Pharmaceuticals (Nasdaq: RPTP) for its Huntington's disease treatment cysteamine bitartrate.
On the downside
Enzymotec (NYSE: ENZY) disappointed with lower second quarter earnings and revenue.
Demandware (NYSE: DWRE) widened losses for the second quarter even as revenue climbed.
Second quarter earnings dropped for Approach Resources (Nasdaq: AREX).
In the broad market, declining issues outpaced advancers by a margin of more than 5 to 2 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 tumbled 18 points to 1920. Bitcoin slipped $4 to $579.
